Indian Pharma Sector Analysis Discontinued

Share |

Publish Date: Jan, 2008 New Report Available

No. of Pages: 100

Format: Adobe Reader (PDF) Upto 24 hour delivery

Description

Table of Content

List of Figures & Tables

1. Analyst View

2. Global Pharmaceutical Market
     2.1 Market Size & Growth
     2.2 Leading Therapy Classes
     2.3 Leading Pharmaceutical Companies
     2.4 Leading Drugs
     2.5 Geographical Performance
     2.6 India - The Emerging Market

3. India - Macroecomomic & Healthcare Profile
     3.1 Macroeconomic Profile
            3.1.1 GDP
            3.1.2 Consumer Price Index
            3.1.3 Currency Fluctuation
            3.1.4 Foreign Direct Investment
     3.2 Population Profile
            3.2.1 Population
            3.2.2 Sex Ratio
            3.2.3 Age Profile
     3.3 Healthcare Profile
            3.3.1 Healthcare Spending
            3.3.2 Sources of Healthcare Payments
            3.3.3 Doctors & Nurses
            3.3.4 Hospitals & Clinics
            3.3.5 Top Causes of Mortality

4. Indian Pharmaceutical Market
     4.1 Turnover
     4.2 Exports & Imports
            4.2.1 Exports
            4.2.2 Imports
     4.3 Bulk Drugs & Formulations

5. Domestic Pharmaceutical Market
     5.1 Drivers
            5.1.1 Ageing Population
            5.1.2 Increasing Income
            5.1.3 Product Patent Regime
            5.1.4 Improving Medical Infrastructure
            5.1.5 Increasing Prevalence of Lifestyle-related Diseases
     5.2 Market Size & Growth
     5.3 Market Segmentation
            5.3.1 By Drugs
                     5.3.1.1 Traditional Branded Generics
                     5.3.1.2 Specialty Branded Generics
                     5.3.1.3 Generic Generics
                     5.3.1.4 Patented Drugs
            5.3.2 By Therapeutics
                     5.3.2.1 Acute Segment
                     5.3.2.2 Chronic Segment
     5.4 Government Regulations & Market Entry
            5.4.1 Industrial & Manufacturing License
            5.4.2 Patent Laws
            5.4.3 Research & Development
            5.4.4 Pricing
            5.4.5 Market Entry
     5.5 Opportunities
            5.5.1 For the Industry
                     5.5.1.1 Biogenerics
                     5.5.1.2 Rural Markets
                     5.5.1.3 Cardiovascular Market
                     5.5.1.4 Diabetes Market
                     5.5.1.5 Asthma Market
                     5.5.1.6 Obesity Market
                     5.5.1.7 Oncology Market
                     5.5.1.8 HIV Market
            5.5.2 By the Industry
                     5.5.2.1 Contract Manufacturing
                     5.5.2.2 Contract Research
                     5.5.2.3 Bioinformatics
                     5.5.2.4 Health Insurance
                     5.5.2.5 Drug Delivery & Packaging Industries
                     5.5.2.6 Pharmaceutical Retail Chains
     5.6 Challenges
            5.6.1 Lack of Innovation
            5.6.2 Drug Price Controls & Low Margins
            5.6.3 Low Per Capita Spending on Drugs
            5.6.4 Multinationals Reluctant to Invest in India
            5.6.5 Counterfeit Drugs
            5.6.6 Low Government Financing
     5.7 Future Outlook
            5.7.1 Market Drivers & Restraints
            5.7.2 Sales (2007-08 to 2011-12)

6. Competitive Landscape
     6.1 Market Structure
     6.2 Market Share of Key Players
     6.3 Profile of Key Players
            6.3.1 Ranbaxy Laboratories Limited
            6.3.2 Cipla Limited
            6.3.3 GlaxoSmithKline Pharmaceuticals Limited
            6.3.4 Nicholas Piramal India Limited
            6.3.5 Zydus Cadila

Not able to find data you are looking for? Ask our Research Analyst.